OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
A randomised, prospective, cross over study will be done to determine whether the anticoagulation therapy with UFH or LMWH used for hemodialysis sessions modifies osteoprotegerin and RANKL plasma levels.
Epistemonikos ID: b28618ef497659ca4d185a6b790e8745ba3fb8ef
First added on: May 05, 2024